About
Technology
Issues
FAQ
Links
Official Page
Preclinical Potency and Safety Studies of an AAV2-Mediated Gene Therapy Vector for the Treatment of
MERTK
Associated Retinitis Pigmentosa
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.